Thymic dendritic cells (DCs) are suggested to be involved in T cell selection; however, their exact origin and function remain to be established. Although DCs in the adult thymus are mostly CD8a
Introduction
Dendritic cells (DCs) are professional antigen-presenting cells (APCs) and play crucial roles for the induction of T cell immunity as well as control of B cells and NK cells (1) . DCs act as a sentinel in peripheral tissues, continuously sampling antigens, and initiate immune responses by presenting antigens to T cells upon encounters with microbial products or tissue damages (2, 3) . In contrast, DCs in the thymus are involved in central tolerance of T cells, which is achieved by inducing apoptosis of self-reactive T cells (4) . A variety of DC subsets have been described based on their cell surface phenotype and morphology and are widely distributed in various tissues including lymphoid and non-lymphoid tissues (5) . However, the developmental origin of DC subtypes has been a controversial issue (6) . Differences in the cytokine and transcriptional factor requirements suggest different developmental pathways for DCs (7) (8) (9) (10) (11) (12) .
In the adult mouse thymus, most DCs are CD8a + CD11b ÿ (13) (14) (15) , but DCs in the fetal thymus are negative for CD8a (16) . A unique feature of thymic DCs is that they can be derived from intra-thymic T/DC precursors and stay in the thymus. It has been shown that T cell precursors have a potential to differentiate into DC in liquid culture and fetal thymus organ culture (FTOC) in the presence of cytokines, or by intra-thymic/intravenous transfer (17) (18) (19) (20) . However, it has also been shown that the development of thymic DC is independent of Notch 1, which is required for early T cell development (21) , and that the development of thymocytes and thymic DCs is dissociated in c-kit/cc-double deficient and RAG2-deficient mice (22) . Also, in the adult mouse thymus, DCs or their precursors are supplied from bloodstream under the steady state (23) . Therefore, the origin of thymic DCs and factors involved in the DC development still remain unclear. While thymic DCs are involved in the establishment of central tolerance including negative selection (4, 24) , a major issue is whether thymic DCs possess distinct immunologic functions or whether their function is determined largely by environmental cues (25) . To address this issue, it is necessary to better understand the nature of thymic DCs. In this report, we describe a novel subset of thymic DCs, CD8a ÿ
CD11b
+ DCs, in the fetal thymus. These cells exhibit strong APC activity and are reduced in TNFR-associated factor 6 (TRAF6)-deficient fetal thymus, suggesting a cytokine that activates TRAF6 is required for thymic DC development. We show that thymic epithelial cells (TECs) express IL-18 and that they induce the differentiation of CD11b + DC from CD4 ÿ CD8 ÿ thymocytes. Finally, we show that the IL-18-induced DCs exhibit strong APC activity and preferentially bind CD4 + CD8 + T (DPT) cells. These results suggest that IL-18 derived from TECs induces the development of a novel class of thymic DCs in the fetal thymus.
Methods

Mice
C57BL/6 and BALB/c mice were purchased from SLC (Shizuoka, Japan). The generation of TRAF6-deficient mice was described previously (26) . The time at midday was taken to be embryonic day (E) 0.5 for the plugged mice. All mice were housed in specific-pathogen-free-barrier animal facilities. All experiments were performed according to our institutional guidelines.
Antibodies and reagents
The following antibodies were used: rat IgG isotype control (R35-95), rat IgM isotype control (R4-22), hamster IgG isotype control (G235-2356), anti-FccR (2.4G2), anti-CD11c (HL3), anti-I-A b (AF6-120.1), anti-CD40 (3/23), anti-CD86 (GL-1), antiCD8a (53-6.7), anti-CD11b (M1/70), anti-CD4 (GK1.5), anti-CD3e (145-2C11), anti-CD25 (7D4), anti-CD44 (IM7) and anti-Thy1.2 antibody (30-H12). All these antibodies were purchased from BD PharMingen (San Diego, CA, USA). Anti-IL-18R a chain (IL-18Ra) antibody was purchased from R&D systems (Minneapolis, USA). Streptavidin-allophycocyanin was purchased from Molecular Probes (Eugene, OR, USA), recombinant murine (rm) stem cell factor (SCF) (100 ng ml ÿ1 ) and rmIL-7 (10 ng ml ÿ1 ) were purchased from PEPROTECH (London, UK), rmIL-1b (5 ng ml ÿ1 ) and rm tumor necrosis factor (TNF)-a (5 ng ml ÿ1 ) were purchased from WAKO (Osaka, Japan), rmIL-18 (12.5 ng ml ÿ1 ) was purchased from MBL (Nagoya, Japan) and oncostatin M (OSM) (10 ng ml ÿ1 ) was purchased from R&D systems.
Flow cytometry and cell sorting
Thymi were disaggregated and filtrated through a 40-lm mesh. Cells suspended in PBS containing 2% fetal bovine serum (FBS) and 2 mM EDTA were pre-treated with blocking antibody against FccR to eliminate non-specific staining. They were then incubated with various antibodies or appropriate isotype-matched control antibodies. After 30 min incubation, cells were washed with PBS and incubated with 7-aminoactinomycin D (7-AAD) (BD PharMingen). After a wash with PBS, cells were suspended in PBS and analyzed by FACSCalibur (BD Bioscience). Dead cells were excluded by 7-AAD staining. Cell sorting was performed with FACSVantage SE (BD Bioscience).
Preparation of primary TECs
Primary TECs were prepared as described (27) . In brief, E16.5 thymi were finely minced and slowly stirred in PBS for 30 min at 4°C to release the bulk of free thymocytes and then digested in a mixture of dispase-collagenase three times for 30 min at 37°C. TECs were precipitated by centrifuging at 800 revolutions per minute and then inoculated into gelatin-coated 12-well plate (7.5 embryos per well) and cultured for 2 weeks in the standard culture medium.
In vitro culture of fetal thymocytes
The culture medium we used was RPMI 1640 (GibcoBRL) supplemented with 10% FBS, 50 lM 2-mercaptoethanol and gentamicin sulfate (the standard culture medium). Thymocytes or sorted double-negative (DN) 1 and DN2 cells from E14.5 fetal thymi were cultured for 6 days in the presence of IL-7 and SCF with or without condition medium (CM) of primary TECs or OSM-responsive TEC line (ORTEC) (28), IL-18 or a combination of IL-1b, IL-3 and TNF-a.
Mixed lymphocytes reaction
Thymic DCs, fetal thymocyte-derived DCs, splenic DCs and LPS-stimulated DCs were used as APCs. Fetal thymocytederived DCs were prepared from E14.5 C57BL/6 thymocytes by culture with ORTEC-CM or IL-18 and the CD11c + I-A b+ population was sorted by FACSVantage SE. Splenic DCs and LPS-stimulated DCs, which were prepared from mice injected with LPS (100 lg per body), were isolated from C57BL/6 spleen by positive selection with the AutoMACS using mAb to CD11c. These APCs were co-cultured with 2 3 10 5 naive CD4 + T cells isolated from BALB/c spleen by positive selection with the AutoMACS using mAb to CD4. Purified T cells were cultured with c ray-irradiated (30 Gy) APCs for 5 days. The culture medium consisted of RPMI 1640 supplemented with 10% FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 0.1 mM non-essential amino acid, 50 lM 2-mercaptoethanol, 10 mM HEPES and gentamicin sulfate (the DC culture medium). T cell proliferation was measured using the WST-1 system (Roche, Switzerland) and the OD 450/650 was measured after 4 h using a microplate reader.
Reverse transcription-PCR
Total RNA prepared by using TRIZOL (Invitrogen) was reverse transcribed with the first-strand cDNA synthesis kit (Amersham Pharmacia) and PCR was performed using the AmpliTaq DNA polymerase kit (Applied Biosystems). Primer sets used were as described previously (28) (29) (30) . After incubation for 2 min at 94°C, PCR amplification was performed using the GeneAmp PCR system (Perkin Elmer) under the following conditions: denaturation at 94°C for 30 s, annealing at the temperature as described in previous reports (28) (29) (30) for 30 s and elongation at 72°C for 1 min. The amplified PCR products were electrophoresed on a 2% agarose gel, and visualized with ethidium bromide. Glyceraldehyde 3-phosphate dehydrogenase was used as an internal control.
ELISA ORTEC was cultured under the standard conditions for DC induction and culture supernatants were recovered. Primary TEC culture supernatant was recovered as described. The supernatants were used for ELISA with the murine IL-18 ELISA kit (MBL) according to the manufacturer's protocol.
RNase protection assay
The RNA probe was made by using mCK-2b multi-probe template sets (BD Bioscience) and labeled with [a-
32 P]uridine 59-triphosphate by in vitro RNA transcription according to the manufacturer's directions. Total RNA was recovered by using TRIZOL (Invitrogen) from E14.5, E16.5, E18.5, P1 and adult thymi. Each 20 lg of RNA was hybridized with 32 P-labeled RNA probe (7.9 3 10 5 counts per minute per sample). RNase treatment was then performed using RNase A and RNase T1. After RNase treatment, samples were electrophoresed. The dried gel was then placed on an Imaging Plate (BAS-MS2040; FUJIFILM, Japan) in a cassette and developed for 12 h at room temperature. The developed Imaging Plate was analyzed with a BAS-1500 bio-imaging analyzer (FUJIFILM). Fig. 2A) . Moreover, expression of CD86, a co-stimulatory molecule, was stronger in CD11b + DCs than CD11b ÿ DCs in the fetal, but not in adult thymus (Fig. 2B ). Consistently, CD11b + DCs in the fetal thymus exhibited APC activity by the allogenic mixed lymphocytes reaction (MLR), similar to that of CD11b ÿ DCs in the adult thymus (Fig. 2C ). Taken together, these results suggest that CD11b + DCs are functionally maturated as APCs and are involved in T cell selection in the fetal thymus.
T/DC conjugation assay
TRAF6 signaling is required for DC development in the fetal thymus IL-1 and TNF-a have been known to induce DCs from thymic precursor cells in vitro (19, 20) and these cytokines activate the nuclear factor-jB signal cascade through the TRAF6 molecule (31) , suggesting that TRAF6 is important for DC development from thymocytes. In fact, Kobayashi et al. (32) recently reported that TRAF6 is essential for the development and maturation of DCs in the adult spleen. We therefore considered the possibility that a cytokine activating the TRAF6 signaling pathway might be also responsible for the development of DCs in the fetal thymus. Although there was no significant difference in the size of thymi between wild-type (WT) and TRAF6-deficient mice, we found that thymic CD11b + DCs were dramatically reduced in TRAF6-deficient mice compared with WT mice (Fig. 3A and B) , whereas no such difference was found in the thymic CD11b ÿ DCs between WT and TRAF6-deficient fetal thymus (Fig. 3C ). Therefore, a factor activating the TRAF6 signaling pathway is required for the development of CD11b + DCs in the fetal thymus.
Development of CD11b + DCs is induced from fetal thymocytes by TECs
As thymic DCs are believed to derive from intra-thymic precursors, we considered the possibility that the thymic environment plays a key role for the development of CD11b + DCs. As TECs are essential for thymic development, we tested whether TECs are involved in DC development. We prepared TECs from E16.5 fetal thymi and cultured for 2 weeks to establish 'primary TEC' (Fig. 4A ) and the culture medium was added to CD4 ÿ
CD8
ÿ thymocytes from E14.5 thymus in the presence of IL-7 and SCF. After 6 days of incubation, a population of CD11c + CD11b + cells developed in this culture, which expressed I-A b and CD86 (Fig. 4B-D ). This result suggested that primary TECs secreted a factor that induces the development of CD11b + DCs from DN thymocytes. As we previously established a TEC line, ORTEC, from fetal thymus (28), we examined the possibility that CD11b + DC development is also supported by ORTEC. The addition of ORTEC-CM to CD4 ÿ CD8 ÿ thymocytes also induced the development of CD11c + CD11b + cells with I-A b , CD86 and CD40 (Fig. 5A) . The APC activity of CD11c + CD11b + cells generated by ORTEC-CM was much higher than that of freshly isolated splenic DCs and was equivalent to that of LPSstimulated splenic DCs (Fig. 5B) , indicating that the CD11c + CD11b + cells generated in vitro by ORTEC-CM are functional DCs. As CD11b + DCs were generated in the culture with ORTEC-CM, it was likely that a cytokine utilizing the TRAF6 signaling pathway was also involved in the development of DCs in vitro.
Differentiation of CD4 ÿ DCs from E16.5 and adult thymus and T cell proliferation was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. T cell proliferation without stimulation was used to normalize the relative APC activity of CD11b + DCs in E16.5 thymus, exhibited APC activity as strong as adult CD11b ÿ DCs, typical adult thymic DCs. Error bars indicate standard deviation. *P < 0.02.
were cultured with IL-7 and SCF in the presence or absence of ORTEC-CM. While both populations proliferated in this culture, DN1 cells proliferated better in the presence of ORTEC-CM than without ORTEC-CM (Fig. 6A ). FACS analysis revealed that both DN1 and DN2 cells produced CD11c + CD11b + cells only in the presence of ORTEC-CM (Fig. 6B and C) . As DN1 cells produced more DCs than DN2 cells, the potential to differentiate to DCs may be gradually reduced during the transition from the DN1 to DN2 stage.
Identification of a factor required for DC development
To identify a factor produced by ORTEC which induces the differentiation of CD11b + DCs from thymocytes, we analyzed the expression of cytokines known to stimulate DC development or to maintain survival of thymocytes by using microarray (data not shown) and reverse transcription (RT)-PCR. Among various cytokines we examined, only IL-18, which is known to activate the TRAF6 signaling pathway, was clearly expressed in ORTEC (Fig. 7A) . None of the other cytokines, IL-1b, IL-3, IL-4, IL-12, TNF-a, granulocyte macrophage colony-stimulating factor and Flt-3L, which are also known to stimulate DC development (19, (33) (34) (35) , was detected in ORTEC (Fig. 7A) . As IL-18 is a member of the IL-1 cytokine family and has been known to activate DCs in the periphery (36), we examined IL-18 expression in more detail. IL-18 was expressed in primary cultured TECs as well as freshly isolated TECs from E16.5 thymus (Fig. 7B) . Furthermore, significant production of IL-18 protein was detected in the culture medium of both primary TECs and ORTEC by ELISA (Fig. 7C) . To assess the expression of IL-18 in the thymus, we performed the RNase protection assay. IL-18 was detected in the thymus from fetus to adult (Fig. 7D) . Consistently with the results for ORTEC, IL-1b expression was not detected in the thymus. Inflammatory cytokines such as IL-6, IL-12, IFN-c and IL-1a were undetectable or barely detectable in the thymus. Interestingly, IL-1R antagonist, which is a specific inhibitor of IL-1 (37, 38) , was constitutively expressed at a high level in the thymus (Fig. 7D) . These results may support the notion that inflammatory responses do not occur in the normal thymus, allowing T cells to develop without interference. In contrast, the IL-18 level was significantly high during thymic development, suggesting that IL-18 plays an important role in thymic microenvironment and is involved in CD11b + DC development from thymocytes.
We examined the expression of IL-18R subunits in DN1 and DN2 cells isolated from E14.5 thymus (Fig. 8A) . In order to avoid contamination of resident DCs and myeloid cells, CD11c + cells were depleted from the DN1 and DN2 cells. RT-PCR analysis revealed that both IL-18Ra and IL-18Rb were expressed in DN1 and DN2 cells but IL-1R (IL-1R1) was not detected in DN1 or DN2 cells (Fig. 8B) . Furthermore, we demonstrated IL-18Ra protein expression on the cell surface of DN1 and DN2 cells (Fig. 8C) . These results strongly suggest Fig. 3 . DC populations in TRAF6-deficient thymus. FACS analysis of TRAF6-deficient E16.5 thymus. Thymocytes from WT and TRAF6 KO mice at E16.5 were stained with antibodies against CD11c and CD11b. CD11c + cell numbers were significantly reduced in TRAF6 KO mice. Thymic CD11c + cells were divided into two populations using anti-CD11b antibody. DC numbers were counted by flow cytometric analysis. Thymic CD11b + DC numbers were significantly reduced in TRAF6 KO mice, while no such change was observed for thymic CD11b ÿ DCs. Results are representative of two independent experiments. Error bars indicate standard deviation. *P < 0.02, **P > 0.1. 
CD8
ÿ thymocytes upon treatment with the combination of IL-1b, IL-3 and TNF-a as reported previously (19) , those DCs (IL-1b-induced DCs) formed T/DC conjugates with a lower extent (11%) than IL-18-induced DCs (Fig. 9C) (Fig. 9D) . In addition, CD11b + DCs from the fetal thymus exhibited a much higher potential to interact with DPT than CD11b ÿ DCs (Fig. 9D) . These results strongly suggest that CD11b + DCs play a major role for T cell development and that IL-18 is involved in the development of functional CD11b + DCs in the fetal thymus.
Discussion
T cell development starts in the fetal thymus and immature thymocytes, the major population in the E16.5 thymus, differentiate into mature T cells via several steps. T cell development in the thymus is most active from fetal to perinatal stages and declines along with aging. A vast majority of T cells are eliminated by positive and negative selection in the thymus and thymic DCs are known to be involved in the establishment of self-tolerance (4, 24) . However, the nature, origin and function of thymic DCs still remain unclear. We have found a novel class of DCs (i.e. CD8a ÿ CD11b + DCs) in the fetal thymus, which require TECs for development and may play a vital role in T cell selection. The CD11b + DCs exhibit potent APC activity and bind DPT cells more efficiently than CD11b ÿ DCs in the fetus ( Figs 2C and 9C and D) . The number of CD11b + DCs is significantly reduced in TRAF6-deficient fetal thymus (Fig. 3) . In consistent with this result, IL-18 produced by TECs induces the development of CD11b + DCs from CD4 ÿ CD8 ÿ thymocytes (Fig. 9A ). Two classes of DCs had been recognized, i.e. DCs in the adult thymus are mostly CD8a + CD11b ÿ , whereas DCs in secondary lymphoid tissues including spleen and lymph nodes are mainly CD8a 
recently reported that DCs in the fetal thymus are negative for CD8a. We confirmed their result and further divided this population into CD11b + and CD11b ÿ (Fig. 1A) . The CD8a ÿ
CD11b
+ population declines after birth and becomes a minor population in the adult thymus (Fig. 1B) . The period in which CD11b + DCs are abundant in the thymus coincides with the period when T cell selection occurs most actively, suggesting that CD11b + DCs may play a vital role in the T cell selection. In fact, CD11b + DCs exhibit stronger APC activity in MLR assays and bind DPT cells more efficiently than CD11b ÿ DCs from the fetal thymus. These results strongly suggest that CD11b + cells are the major APCs for the DPT cells in the fetal thymus. CD11b + DCs are reduced in TRAF6-deficient thymus (Fig. 3B ) and TRAF6 deficiency in the thymus causes symptoms of autoimmunity (41) . Thus, CD11b + DCs may be involved in T cell selection as discussed below.
Thymic DCs are derived from intra-thymic precursors and we found that DN1 and DN2 cells give rise to CD11b + DCs. As DN cells are a heterogeneous population, the exact origin of thymic DCs remains unknown. It was reported that thymic DCs were derived from T/DC precursors, while some DCs or their immediate precursors were reported to derive from the bloodstream in the adult thymus (23) . Thus, whether thymic DCs derive from T cell precursors or myeloid precursors in the thymus has been a controversial issue. We show in this paper that the development of CD11b + DCs from DN cells is induced by IL-18. The IL-18R was expressed in a significant fraction of DN1 and DN2 cells, in which the CD11c population was excluded to avoid a DC contamination for RT-PCR analysis. In addition, IL-7 is known to be required for survival and proliferation of lymphoid progenitors and we found that IL-18 strongly induced CD11b + DCs in the presence of IL-7 (data not shown). Although we did not find evidence for TCRb rearrangement in the CD11b + DCs (data not shown), it was reported that thymic DCs are derived from intra-thymic precursor at a stage before TCRb rearrangement (20) . Thus, while it remains possible that CD11b + DCs derive from a minor population of myeloid precursors with the IL-18Rs in the fetal thymus, it is strongly suggested that IL-18 produced from TECs induces development of DCs from intra-thymic T cell progenitors and that the IL-18R is an excellent marker for CD11b + DC progenitors in the fetal thymus. TEC is known to play a role in the positive selection of T cells by expressing MHC (42) (43) (44) and we recently showed that TECs play an active role in the development of thymic CD4 + macrophages from T cell progenitors (28, 29) . We now show that TECs produce a factor, IL-18, which induces the differentiation of DCs from DN cells, suggesting that TECs play crucial roles in the T cell development by producing APCs (DCs) for Tcell selection and scavengers (CD4 + macrophages) for the clearance of apoptotic Tcells in the thymus. Consistently, it was recently shown that splenic stroma cells play a crucial role for the maturation of DCs in the spleen (45) . Thus, microenvironment is an important determinant of the DC fate.
It was recently reported that CD4 + CD11b + splenic DCs, which exhibited characteristics of myeloid DCs, are nearly absent in TRAF6-deficient mice and TRAF6-deficient DCs are unable to up-regulate the surface expression of I-A b , CD86 and inflammatory cytokines in response to microbial components, indicating an essential role for TRAF6 in the development and maturation of DCs in the adult spleen (32) . In the 14-day-old mice, although hypoplasia of medullary TECs and reduced number of thymocytes were observed in TRAF6-deficient thymus, maturation and the absolute number of T cells were not significantly affected (41) . However, in the neonatal thymus, the size and absolute cell numbers of thymi were not significantly different between WT and TRAF6-deficient mice (Akiyama et al., unpublished observation). Taken together, it is suggested that the absolute number of thymocytes in the E16.5 thymi is not significantly different between WT and TRAF6-deficient mice. We found a significant reduction of thymic CD11b + DCs in the E16.5 thymus of TRAF6-deficient mice, indicating that a cytokine acting on the TRAF6 signaling pathway is required for the development of DCs in the fetal thymus in vivo. Among the cytokines known to activate TRAF6, only IL-18 was found to be abundantly expressed in TECs (Fig. 7A-C) . While IL-18 production has been shown in macrophages, DCs, keratinocytes, osteoblasts and various epithelial cells (46, 47) , in our knowledge this is the first report that IL-18 is produced by TECs. IL-18 expression in the thymus increases along with development ( Fig. 7D ) and the IL-18R is expressed on DN cells. Most significantly, IL-18 directly induces the differentiation of DN1 and DN2 cells into CD11b + DCs (Fig. 9A) . In contrast to fetal thymus, the fraction of CD11b + DCs is very low in the adult thymus ( Fig. 1A and B) and IL-18 failed to induce the development of CD11b + DCs from adult CD4 ÿ CD8 ÿ thymocytes (data not shown). Although IL-18 expression was observed in the adult thymus (Fig. 7D) , IL-18R expression in adult CD4 ÿ
CD8
ÿ thymocytes was low; in particular, expression of IL-18Rb, which is important for signal transduction, was undetectable. These results indicate that IL-18 does not induce CD11b + DCs in the adult thymus due to the lack of functional IL-18R in adult CD4 ÿ CD8 ÿ thymocytes. On the other hand, we found that the combination of IL-1b, IL-3 and TNF-a induced the development of CD11b + DCs from adult CD4 ÿ
ÿ thymocytes as previously reported (19) . To address the function of IL-18 for fetal thymic DC development in vivo, we assessed CD11b + DC development in IL-18Ra-deficient fetal thymus (48) and found that the development of CD11b + DCs was not severely affected in IL18Ra-deficient fetal thymus (Ito et al., unpublished observation). In consistent with this observation, IL-18 antagonists, i.e. IL-18-binding protein and neutralizing anti-IL-18Rb antibody, failed to inhibit the development of CD11b + DCs from fetal thymocytes in the presence of ORTEC-CM. These results indicate the presence of another cytokine with the ability to induce CD11b + DC via the TRAF6 signaling pathway in the fetal thymus. Because cytokines in the IL-1 family as well as the TNF-a family utilize the TRAF6 signaling pathway and there are still several members in both families which have not been well characterized (31, 49, 50) , such cytokines may be a good candidate. Furthermore, novel factors that activate TRAF6 may be present in the fetal thymus and support CD11b + DC development. In any cases, CD11b + DCs generated by IL-18 in vitro show strong APC activity and the ability of DPT recognition in a manner similar to the CD11b + DCs freshly isolated from the fetal thymus (Fig. 9) . It is thus tempting to speculate that the CD11b + DCs play a vital role for T cell + cells is shown. The result indicates that IL-18-induced DCs as well as thymic CD11b + DCs exhibit greater potential to bind DPT than IL-1b-induced DCs and thymic CD11b ÿ DCs. Results are representative of two independent experiments. All experiments were performed in triplicate and error bars indicate standard deviation. *P < 0.02, **P > 0. 1. selection by inducing apoptosis of DPT in the conjugates between DPT and DCs. Although DCs can be derived in vitro from thymocytes by the combination of cytokines, IL-1b, IL-3, TNF-a, IL-7 and SCF, the APC activity as well as binding of those DCs to DPT cells is much weaker than that of IL-18-induced DCs. Thus, it is likely that the thymic CD11b + DCs are novel DCs involved in the T cell selection during the perinatal stage. As TRAF6-deficient thymus develops autoimmune disease (41) , the impaired development of CD11b + DCs in the thymus may be one reason for the development of autoimmunity. A detailed analysis of the interaction between CD11c + CD11b + cells and DPT cells will provide key information as to the molecular mechanism of T cell selection in the thymus and may also provide a molecular basis for the development of autoimmunity.
Among the B7 family, CD80 and CD86 on DCs are known to be involved in T cell stimulation via CD28 and CTLA-4 on T cells. Although B7 family members are important for peripheral immune responses, the role of CD80 and CD86 in negative selection still remains unclear, e.g. mice devoid of CD80 or CD86 show a little defect in T cell selection (51). While we found a high level of CD86 in CD11b + thymic DCs, its role in DC functions remains to be investigated. A major obstacle to the analysis of thymic DCs has been that they are a very rare population. In this study, we have successfully developed a means to produce a large quantity of functional thymic DCs from immature thymocytes in vitro. Studies using these DCs will provide valuable information on the function of thymic DCs in vivo and also roles of co-stimulatory molecules in T cell selection.
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